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1. Introduction 
AMP-deaminase is an allosteric enzyme that exists 
in several molecular forms [l-3]. Characterization of 
the antigenic structure of this enzyme is of interest 
because specific antibodies are useful probes for 
detecting developmental differences in isozyme dis- 
tribution [4]. Interest in this protein as an antigen 
also arises from the observation that immunization of 
rabbits with skeletal muscle AMP-deaminase elicits 
production of circulating auto-antibody [S]. 
In an earlier report we compared the effect of 
rabbit antibody directed against homogeneous avian 
breast muscle AMP-deaminase on the enzymatic activ- 
ity in relatively crude preparations from brain and 
erythrocytes [ 11. We have now purified erythrocyte 
AMP-deaminase -7000.fold and have carried out a 
reciprocal study of the interaction between rabbit 
antibody directed against highly-purified erythrocyte 
AMP-deaminase and purified isozymes from breast 
muscle and erythrocytes. 
The degree to which these isozymes share similar 
sequence and/or conformational antigenic determi- 
nants is not known. However, it is now clear that 
these isozymes are very similar with respect to the 
molecular weights of the native enzymes (i.e., 
276 000), that each enzyme is a tetramer of subunits 
of identical size (i.e., 69 000; [6]), and that their 
amino acid compositions are similar, but not identical 
(Kruckeberg, S. L. and 0. P. C., unpublished observa- 
tions). 
Antibodies obtained from rabbits following 
* To whom correspondence should be addressed 
Elsevier/North-Holland Biomedical Press 
immunization with highly purified AMPdeaminase 
from chicken erythrocytes can inhibit > 90% of the 
enzymatic activity of highly purified AMP-deaminases 
from both avian erythrocytes and breast muscle, 
depending upon the substrate concentration used for 
assay of enzymatic activity. However, a much greater 
amount (- 5.fold) of antibody was required to inhibit 
the muscle isozyme than was needed to obtain an 
equivalent degree of inhibition of a comparable 
amount of erythrocyte AMP-deaminase. 
It is concluded that the AMP-deaminase isozymes 
from avian erythrocytes and breast muscle, though 
not identical, share similar antigenic determinants. 
2. Materials and methods 
All chemicals were of reagent grade and were 
obtained from the sources reported in [ 11. 
AMP-deaminase was isolated from lysates of adult 
chicken (Callus dome&us) erythrocytes by a proce- 
dure to be described in detail elsewhere (Kruckeberg, 
S. L. and 0. P. C., unpublished results). Breast muscle 
AMP-deaminase was purified as in [S]. 
Rabbit antisera directed against purified erythro- 
cyte AMP-deaminase (spec. act. 950 U/mg) were 
obtained as follows: 0.5 mg lyophllized enzyme in 
0.5 ml phosphate buffered saline (PBS; 8.8 g NaCl 
+ 7.0 g NaH,P04 . Hz0 per liter) was emulsified with 
0.5 ml complete Freund’s adjuvant and injected at 
multiple sitesin the neck region. A secondary response 
was elicited by injection of 1 mg lyophilized enzyme 
in 1 ml PBS in the ear vein on days 32,34,37 and 39 
after the primary injection. The antisera used in the 
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studies to be described here were obtained from blood 
samples collected from the marginal ear vein on days 
41 and 60, following the primary injection. Rabbit 
antisera directed against homogeneous AMPdeaminase 
from chicken breast muscle were obtained as in [5]. 
Purified immunoglobulin fractions were isolated from 
pre-immune (control) sera and anti-sera by sodium 
sulfate fractionation as in [7]. Sera and immunoglob- 
ulin fractions were stored at -2O’C. Double diffusion 
(Ouchterlony) tests were carried out as in [S]. Immuno- 
inhibition of enzymatic activity was assayed as in 
[ 1,5]. The buffer used for assays of enzymatic activity 
contained 150 mM KCl t 50 mM Tris-(hydroxy- 
methyl)-amino methane 2- [N-morpholino] ethane 
sulfonic acid (pH 6.5, Tris-MES) instead of Tris- 
succinate. Details regarding individual experiments 
are provided in figure legends. 
3. Results 
Rabbit antibody directed against purified erythro- 
cyte AMPdeaminase inhibits the enzymatic activity 
of this isozyme; the extent of this inhibition varies 
with the concentration of 5’-AMP that is used in the 
assay of activity after preincubation with antiserum. 
The data summarized in fig.1 show that at antibody 
to enzyme ratios which showed > 90% inhibition, 
when assayed at 100 PM 5’-AMP, showed - 50% inhi- 
bition when these mixtures were assayed at 30 mM 
5’-AMP. Approximately 90% inhibition was observed, 
even when assayed at 30 mM 5’-AMP, when the ratio 
of antiserum to enzymatic activity was increased to 
50 X 10e3 ml/U (data not shown). 
Double diffusion analysis showed a single, sharp 
precipitin band when these antisera were tested against 
erythrocyte AMP-deaminase, but similar experiments, 
using the muscle isozyme, were uniformly negative, 
suggesting strict antibody specificity for the erythro- 
cyte enzyme (Kruckeberg, S. L. and 0. P. C., unpub- 
lished observations). However, positive evidence that 
rabbit antierythrocyte AMPdeaminase interacts with 
muscle AMPdeaminase was obtained from enzyme 
inhibition experiments. 
Typical data are summarized in table 1. In exp. 1, 
equal amounts of purified AMPdeaminase from 
muscle and erythrocytes were incubated with fixed 
amounts of antiserum (directed against the RBC 
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Fig.1. Inhibition of AMPdeaminase from chicken erythro- 
cytes by rabbit antibody directed against he erythrocyte 
enzyme. (0) Aliquots (- 10 pg each) of purified erythrocyte 
deaminase were incubated for 30 min at room temperature 
with increasing amounts (4-30 ~1) antiserum, obtained from 
rabbits that were immunized with purified erythrocyte AMP- 
deaminase, or control serum obtained prior to immunization. 
Incubation mixtures were brought to total vol. 100 ~1 with 
phosphate-buffered saline (8.8 g NaCl+ 7.0 gNaH,PO, . H,O). 
Aliquots of these incubation mixtures were then assayed by 
the continuous spectrophotometric assay referenced under 
section 2,100 PM Y-AMP in 150 mM KC1 + 50 mM Tris-MES, 
pH 6.5. (4) Same as (o), except 4.5 pg enzyme was incubated 
with antiserum (or control serum) 5-50 ~1, in total vol. 875 ~1 
and assayed by the discontinuous assay of ammonia produc- 
tion at 30 mM 5’-AMP. 
enzyme) and assayed at 30 mM 5’-AMP. Under condi- 
tions where 61% activity of the RBC isozyme was 
inhibited, low, but significant inhibition (i.e., 11%) of 
the muscle enzyme was observed, In exp. 2, using an 
antiserum obtained at a different stage in the course 
of immunization, inhibition of the muscle isozyme 
was increased to 32%. Inhibition of muscle AMP- 
deaminase by rabbit antierythrocyte AMP-deaminase 
was also dependent on substrate concentration; when 
assayed at 100 PM 5’-AMP the degree of inhibition 
was 87% (expt 2, table 1). 
Parallel double diffusion and immunoinhibition 
experiments, using rabbit antibodies directed against 
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Table 1 
Inhibition of avian muscle and erythrocyte AMPdeaminases 
by rabbit antierythrocyte AMPdeaminase 
Enzyme 
source 
Assay 
[AW 
% Inhibi- 
tion 
Expt. la 
Expt. 2b 
Muscle 
Erythrocytes 
Muscle 
Muscle 
30mM 11 
30mM 61 
30mM 32 
100/~M 87 
a The antiserum used for this experiment is the same one that 
was used to obtain the data that are summarized in fK.1. 
Muscle and erythrocyte enzymes were incubated with anti- 
serum or control serum at a ratio of 7 rl/unit enzymatic 
activity. Following incubation for 30 min at room tempera- 
ture enzymatic activity was determined by the discontinu- 
ous assay of ammonia proddction 
b The antiserum used for this experiment was from a different 
bleeding, obtained at a different stage of immunization 
than for expt. 1. The ratio of antiserum (or control serum) 
to enzymatic activity was 2.1 ccl/unit enzymatic activity. 
Enzymatic activity was determined either by the discontin- 
uous assay of ammonia production (at 30 mM 5’-AMP) or 
by the continuous spectrophotometric assay (at 100 PM 
Y-AMP) 
breast muscle AMP-deaminase, yielded reciprocal 
results. Precipitin bands were obtained with muscle 
enzyine in the antigen wells but no bands were observed 
when this antiserum was tested against erythrocyte 
enzyme. Inhibition of the enzymatic activity of 
muscle AMP-deaminase was virtually complete over a 
5-fold range of antigen: antibody ratios, when assayed 
at 100 E.IM 5’-AMP. Greater than 95% inhibition of 
erythrocyte AMP-deaminase by rabbit anti-muscle 
AMP-deaminase was also observed; however, - 5-fold 
greater amounts of antibody were required (data not 
shown). 
4. Discussion 
The lmmunoinhibition data we have presented 
show that muscle and erythrocyte AMP-deaminases 
share similar antigenic determinants. The mecha- 
nism by which immunoinhibition is diminished at 
elevated substrate concentration is not known. The 
AMP-deaminase isozymes are both allosteric pro- 
teins [ 1,6]. Thus it is possible that an allosteric 
transition occurs as the level of 5’-AMP is raised, 
producing a more active conformation or exposing 
one or more active sites that were not accessible to 
antibody, during preincubation of the antigen-anti- 
body mixture. It is also possible that in the presence 
of 30 mM 5’-AMP the antigen-antibody complex 
dissociates (at least partially). Another explanation 
that is consistent with the data is that antibody does 
not interact with substrate binding or catalytic sites 
directly, but favors an enzyme conformation having 
low affinity for substrate. By this mechanism elevated 
levels of substrate would increase enzymatic rates via 
saturating these low affinity sites. 
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